Idiopathic pulmonary fibrosis (IPF) is a chronic condition of unknown etiology with an
unfavorable outcome from progressively deteriorating respiratory function, leading ultimately …

Idiopathic pulmonary fibrosis (IPF) is a chronic condition of unknown aetiology with
deteriorating respiratory function leading to respiratory failure. Sequential acute lung injury …

The clinical course of idiopathic pulmonary fibrosis (IPF) is variable; however, the long-term
survival in IPF is poor. Prednisone has been the mainstay of therapy since its release for …

Idiopathic pulmonary fibrosis (IPF) is a highly lethal disorder associated with an extremely
poor prognosis and poor survival in most patients. Higher mortality rates attributable to …

The patient with suspected idiopathic pulmonary fibrosis (IPF) poses a significant problem in
diagnosis and management of this disease. Although intense research over the past decade …

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic fibrosing interstitial
pneumonia of unknown aetiology and is associated with the histological picture of usual …

The long-standing need to determine an effective medical treatment regimen with clinically
significant and relevant end-points to improve outcome for patients with idiopathic …

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic fibrosing interstitial
pneumonia limited to the lung and associated with the histologic appearance of usual …

Idiopathic pulmonary fibrosis (IPF), or crypto-genic fibrosing alveolitis, is a disorder
characterized by intense alveolar inflammation, disruption of the pulmonary vascular bed …

BACKGROUND: The consensus statement on the Diagnosis and Therapy of Idiopathic
Pulmonary Fibrosis (IPF) formulated by the American Thoracic Society/European …